Unadjusted OR (95% CI) | P-value | Adjusted OR (95% CI) | P-value | |
---|---|---|---|---|
Year | 1.2 (1.17 - 1.22) | <0.001 | 1.18 (1.16 - 1.21) | <0.001 |
Ethnicity | ||||
White | 1.00 (reference) | 1.00 (reference) | ||
Non-white | 0.98 (0.86 - 1.1) | 0.70 | 0.97 (0.84 - 1.11) | 0.62 |
Risk group | ||||
Heterosexual man | 1.00 (reference) | 1.00 (reference) | ||
Heterosexual woman | 0.83 (0.7 - 0.98) | 0.03 | 0.93 (0.78 - 1.12) | 0.46 |
MSM | 1.02 (0.86 - 1.2) | 0.85 | 1.05 (0.87 - 1.27) | 0.61 |
IDU | 0.48 (0.31 - 0.75) | <0.01 | 0.88 (0.5 - 1.56) | 0.66 |
Unknown | 0.99 (0.8 - 1.27) | 0.91 | 1.08 (0.86 - 1.37) | 0.50 |
Other | 0.46 (0.28 - 0.75) | <0.001 | 0.78 (0.46 - 1.3) | 0.34 |
Education (years) | ||||
≤8 | 1.00 (reference) | 1.00 (reference) | ||
>8 | 1.66 (1.46 - 1.88) | <0.001 | 1.69 (1.47 - 1.95) | <0.001 |
Age* (years) | ||||
<30 | 1,00 (reference) | 1.00 (reference) | ||
30-39 | 1.14 (0.94 - 1.37) | 0.19 | 1.22 (0.98 - 1.5) | 0.07 |
40-49 | 1.55 (1.27 - 1.88) | <0.001 | 1.68 (1.34 - 2.11) | <0.001 |
≥50 | 1.98 (1.57 - 2.49) | <0.001 | 2.11 (1.61 - 2.77) | <0.001 |
Years since HIV diagnosis* | 0.98 (0.97 - 1) | 0.01 | 0.92 (0.91 - 0.94) | <0.001 |
Pre-treatment CD4+ | ||||
≤200 | 1.00 (reference) | 1.00 (reference) | ||
201-350 | 1.01 (0.87 - 1.18) | 0.87 | 0.97 (0.82 - 1.14) | 0.73 |
351-500 | 1.19 (0.95 - 1.5) | 0.12 | 1.3 (1.02 - 1.64) | 0.03 |
>500 | 0.64 (0.49 - 0.83) | <0.001 | 0.93 (0.7 - 1.24) | 0.62 |
Missing | 0.75 (0.62 - 0.89) | <0.001 | 0.84 (0.69 - 1.02) | 0.08 |
Initial regimen | ||||
NRTI + NNRTI | 1.00 (reference) | 1.00 (reference) | ||
NRTI + PI | 0.56 (0.5 - 0.64) | <0.001 | 0.72 (0.63 - 0.83) | <0.001 |
ART interruption* | ||||
≤1 month | 1.00 (reference) | 1.00 (reference) | ||
>1 month | 0.29 (0.25 - 0.37) | <0.001 | 0.32 (0.27 - 0.38) | <0.001 |
Hep C coinfection* | 1.01 (0.8 - 1.27) | 0.95 | 1.09 (0.84 - 1.42) | 0.50 |